Study: Effects of Kre-Alkalyn® on Cellular Protein Metabolism In-vitro

Science for Humans #1651: Vitamin B3
Science for Humans #1651: Vitamin B3
June 3, 2015
Science for Humans #1656: The B Vitamin "From Everywhere"
Science for Humans #1656: The B Vitamin “From Everywhere”
June 10, 2015
Science for Humans #1651: Vitamin B3
Science for Humans #1651: Vitamin B3
June 3, 2015
Science for Humans #1656: The B Vitamin "From Everywhere"
Science for Humans #1656: The B Vitamin “From Everywhere”
June 10, 2015
Show all

Study: Effects of Kre-Alkalyn® on Cellular Protein Metabolism In-vitro

Kre-Alkalyn® –Vs– Creatine Monohydrate Effects of Creatine Supplementation on the Cellular Protein Metabolism In-vitro

Jeff Golini, Ph.D., Kamen Stroychev, M.D.
All American Pharmaceutical, Billings, MT, and I.S. Greenberg Medical Center, Sofia, Bulgaria

Study Objectives

We sought to examine the effect of the stabilization processing (Kre-Alkalyn®) upon the cellular metabolic effects in muscle and cartilage cells.

Patients and Methods

An established monolayer culture of muscle cells (RD) or chondrocytes (SW1353) were subcultured in a deficient medium containing only 2.5 % fetal calf serum, instead of 10% which is mandatory for optimal cell growth and maintenance in-vitro. Clls were then exposed to either culture medium (controls) or 0.5 mmol conventional creatine or buffered creatine (Kre-Alkalyn®). After 12 hrs, 24 hrs or 48 hrs exposure, the cells were detached by trypsinization, washed three times in PBS to remove residual protein from the culture medium, and counted. The protein content in each sample was determined using the Lowry method. The results were calculated as mgs of protein/106 cells, and expressed as a percentage of the untreated control.

Results

(Detailed numbers can be seen by clicking the Research Poster Presentation image below)

Summary and Conclusions

An alkalized creatine (Kre-Alkalyn®) proved to be more anabolic in both cell lines compared to regular creatine monohydrate.

Research Poster Presentation Image:

Dr. Jeff Golini
Dr. Jeff Golini
Dr. Jeff Golini is the Founder, CEO and Executive Scientist of All American Pharmaceutical. He holds numerous patents for innovative compounds such as, Kre-Alkalyn buffered creatine monohydrate, Karbolyn, the high-performance carbohydrate, and Kre-Celazine.

Comments are closed.